Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Ngan

Showing results (221-230 of 261) with videos related to

Pageof 27
Sort By:
The Journal of Molecular Diagnostics : JMD|February 1, 2005
Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinomaQueeny K Y Chan, Ui-Soon Khoo, Kelvin Y K Chan, et al.
Scientific Reports|March 10, 2022
A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancerAya El Helali, Charlene H L Wong, Horace C W Choi, et al.
Histopathology|February 22, 2005
Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysisS S Li, W C Xue, U S Khoo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroupGiorgia Mangili, Domenica Lorusso, Jubilee Brown, et al.
The Journal of Molecular Diagnostics : JMD|February 19, 2020
Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test PanelAva Kwong, Vivian Y Shin, Jiawei Chen, et al.
Plos One|July 29, 2015
p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell ProliferationMichelle K Y Siu, Daniel S H Kong, Sheila Y P Ngai, et al.
BMC Pregnancy and Childbirth|February 16, 2022
Validating the use of the revised childbirth experience questionnaire in Hong KongKris Y W Lok, Heidi S L Fan, Rachel W T Ko, et al.
Cancer Research|September 2, 2008
Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cellsWen Deng, Sai Wah Tsao, Yvonne K Kwok, et al.
Histopathology|November 20, 2016
The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based studyKin-Long Chow, Ka-Yu Tse, Ching-Lung Cheung, et al.
Cancers|February 15, 2022
Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian Tumour Analysis (IOTA) Simple RulesSiew Fei Ngu, Yu Ka Chai, Ka Man Choi, et al.
Pageof 27

Showing results (221-230 of 261) with videos related to

Sort By:
Pageof 27
The Journal of Molecular Diagnostics : JMD|February 1, 2005
Promoter methylation and differential expression of pi-class glutathione S-transferase in endometrial carcinomaQueeny K Y Chan, Ui-Soon Khoo, Kelvin Y K Chan, et al.
Scientific Reports|March 10, 2022
A comprehensive systematic review and network meta-analysis: the role of anti-angiogenic agents in advanced epithelial ovarian cancerAya El Helali, Charlene H L Wong, Horace C W Choi, et al.
Histopathology|February 22, 2005
Replicative MCM7 protein as a proliferation marker in endometrial carcinoma: a tissue microarray and clinicopathological analysisS S Li, W C Xue, U S Khoo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|October 25, 2014
Trophoblastic disease review for diagnosis and management: a joint report from the International Society for the Study of Trophoblastic Disease, European Organisation for the Treatment of Trophoblastic Disease, and the Gynecologic Cancer InterGroupGiorgia Mangili, Domenica Lorusso, Jubilee Brown, et al.
The Journal of Molecular Diagnostics : JMD|February 19, 2020
Germline Mutation in 1338 BRCA-Negative Chinese Hereditary Breast and/or Ovarian Cancer Patients: Clinical Testing with a Multigene Test PanelAva Kwong, Vivian Y Shin, Jiawei Chen, et al.
Plos One|July 29, 2015
p21-Activated Kinases 1, 2 and 4 in Endometrial Cancers: Effects on Clinical Outcomes and Cell ProliferationMichelle K Y Siu, Daniel S H Kong, Sheila Y P Ngai, et al.
BMC Pregnancy and Childbirth|February 16, 2022
Validating the use of the revised childbirth experience questionnaire in Hong KongKris Y W Lok, Heidi S L Fan, Rachel W T Ko, et al.
Cancer Research|September 2, 2008
Transforming growth factor beta1 promotes chromosomal instability in human papillomavirus 16 E6E7-infected cervical epithelial cellsWen Deng, Sai Wah Tsao, Yvonne K Kwok, et al.
Histopathology|November 20, 2016
The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based studyKin-Long Chow, Ka-Yu Tse, Ching-Lung Cheung, et al.
Cancers|February 15, 2022
Diagnostic Performance of Risk of Malignancy Algorithm (ROMA), Risk of Malignancy Index (RMI) and Expert Ultrasound Assessment in a Pelvic Mass Classified as Inconclusive by International Ovarian Tumour Analysis (IOTA) Simple RulesSiew Fei Ngu, Yu Ka Chai, Ka Man Choi, et al.
Pageof 27